-
221
-
222
Two Cases of Ectopic Hamartomatous Thymoma Masquerading as Sarcoma
Published 2017-01-01Get full text
Article -
223
-
224
-
225
-
226
Personalized allele-specific antisense oligonucleotides for GNAO1-neurodevelopmental disorder
Published 2025-03-01Get full text
Article -
227
Novel In Vitro Assays for the Characterization of EMT in Tumourigenesis
Published 2010-01-01Get full text
Article -
228
Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer
Published 2009-01-01Get full text
Article -
229
-
230
-
231
miR‐130a‐3p regulated TGF‐β1‐induced epithelial‐mesenchymal transition depends on SMAD4 in EC‐1 cells
Published 2019-03-01Get full text
Article -
232
D-2-hydroxyglutarate impairs DNA repair through epigenetic reprogramming
Published 2025-02-01Get full text
Article -
233
Exploring PANoptosis in head and neck cancer: A novel approach to cancer therapy
Published 2025-01-01“…PANoptosis is a newly discovered complex programmed cell death (PCD) form. In the field of cancer research, PANoptosis is involved in multiple cell death pathways that affect tumor cell survival, proliferation, and response to treatment, serving as an innovative strategy for cancer therapy. …”
Get full text
Article -
234
Centrosome amplification and aneuploidy driven by the HIV-1-induced Vpr•VprBP•Plk4 complex in CD4+ T cells
Published 2024-03-01Get full text
Article -
235
Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment
Published 2025-01-01Get full text
Article -
236
-
237
RevCAR-mediated T-cell response against PD-L1-expressing cells turns suppression into activation
Published 2025-02-01Get full text
Article -
238
-
239
Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing
Published 2025-02-01Get full text
Article -
240